Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of April 15, 2025, Argenx (ARGX) has a market cap of $36.92 billion USD. According to our data, Argenx is ranked No.526 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Apr 15, 2025 | $36.92 B |
-1.19%
|
| Dec 31, 2024 | $37.37 B |
61.66%
|
| Dec 29, 2023 | $23.12 B |
0.42%
|
| Dec 30, 2022 | $23.02 B |
8.18%
|
| Dec 31, 2021 | $21.28 B |
19.08%
|
| Dec 31, 2020 | $17.87 B |
83.21%
|
| Dec 31, 2019 | $9.75 B |
67.09%
|
| Dec 31, 2018 | $5.84 B |
52.15%
|
| Dec 29, 2017 | $3.84 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 BioMarin Pharmaceutical
BMRN
|
$11.51 B |
-0.000 M
|
USA
|
 Regeneron Pharmaceuticals
REGN
|
$60.99 B |
1.014 B
|
USA
|
 Amgen
AMGN
|
$158.77 B |
0.132 B
|
USA
|
 Gilead Sciences
GILD
|
$131.74 B |
-0.002 M
|
USA
|
 Biogen
BIIB
|
$17.12 B |
0.000 M
|
USA
|
 Moderna
MRNA
|
$10.14 B |
-0.001 M
|
USA
|
 Novavax
NVAX
|
$1.03 B |
0.000 M
|
USA
|
 Alnylam Pharmaceuticals
ALNY
|
$29.89 B |
-0.001 M
|
USA
|
 Sarepta Therapeutics
SRPT
|
$5.28 B |
-0.000 M
|
USA
|
 Ultragenyx
RARE
|
$3.32 B |
0.000 M
|
USA
|
 Ionis Pharmaceuticals
IONS
|
$4.51 B |
0.000 M
|
USA
|
 bluebird bio
BLUE
|
$43.76 M |
0.000 M
|
USA
|
| Market Cap | = | ARGX Stock Price | * | ARGX Shares Outstanding |
| = | $605.38 | * | 60.99 M | |
| = | $36.92 B |